Drugs / Adipose derived Stromal cells (ADSCs)
Adipose derived Stromal cells (ADSCs)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02603744 | Jun 2015 → Jun 2018 | primary ovarian failure | Royan Institute | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adipose derived Stromal cells (ADSCs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02603744 ↗ |
| Modality | Cell therapy | “autologous adipose-derived stromal cells (ADSCs)” PMID 33407794 ↗ Jan 2021 |
| Route | Other | “intra-ovarian injection” NCT02603744 ↗ |